BRISTOL-MYERS SQUIBB COMPANY Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount of $2.60 billion for the 12-month period ending 2017-12-31, per its 10-Q filed 2018-10-25.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationRepatriationOfForeignEarnings · last filed 2018-10-25
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, repatriation of foreign earnings, amount for the quarter ending 2010-12-31 was $207.00M.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, repatriation of foreign earnings, amount for fiscal 2010 was $207.00M.
| Period end | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount 3 month | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount 12 month |
|---|---|---|
| 2017-12-31 | $2.60B 10-Q · filed 2018-10-25 | |
| 2010-12-31 | $207.00M 10-K · filed 2012-02-17 | $207.00M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |